The 'Phoenix' ADR database of the Drug Commission of the German Medical Profession - A clinically useful approach to optimize evidence-based medicine in Germany

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 1, 1999, Pages 57-64

  Munter, Karl Heinz ^a   Schenk, Joachim F ^b   Thrun, Frank ^a   Tiaden, Jöerg David ^a   Wenzel, Ernst ^b   Müller Oerlinghausen, Bruno ^a  

^a Drug Comm of the Ger M Profession   (Germany)

^b University Clinics   (Germany)

Author keywords

Adverse drug reactions; Drug Commission of the German Medical Profession; Evidence Based Medicine (EBM); Phoenix database

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; CLINICAL PRACTICE; DATA BASE; EVALUATION; EVIDENCE BASED MEDICINE; GERMANY; HEALTH PROGRAM; INFORMATION RETRIEVAL; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; PRIORITY JOURNAL;

EID: 0032930896     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996425     Document Type: Article

References (7)

1. 1. Cook D. Evidence-based critical care medicine: A potential tool for change. New Horizons 1998;6:20-25
2. 2. Jenicek M. Epidemiology, evidence-based medicine, and evidence-based public health. J Epidemiol 1997;7:187-197
3. 3. Green ML, Ellis PJ. Impact of an evidence-based medicine curriculum based on adult learning theory. J Gen Intern Med 1997; 12:742-750
4. 4. Porszolt F, Kunz R. Differences between evidence-based-medicine and best conventional medicine. Med Klinik 1997;92:567-569
5. 5. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. Br Med J 1996;312:71-72
6. 6. Schenk JF , Mörsdorf S, Thrun F, et al. Analysis and occurence of adverse events in oral anticoagulant therapy. Semin Thromb Hemostas 1999;25:65-71
7. 7. Schenk JF, Mörsdorf S, Munter KH, et al. Optimized therapy with oral anticoagulants. Risk benefit analysis. Danubean League against Thrombosis and Hemorrhagic Disorders. 11th Meeting, Frankfurt/M - Germany, 1998